IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 42 filers reported holding IMMUNOCORE HLDGS PLC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,217,438 | -13.1% | 485,886 | +0.4% | 0.02% | -10.0% |
| Q2 2023 | $29,006,074 | +29.3% | 483,757 | +6.6% | 0.02% | +25.0% |
| Q1 2023 | $22,436,069 | -21.7% | 453,804 | -9.6% | 0.02% | -27.3% |
| Q4 2022 | $28,648,172 | +16.0% | 501,983 | -4.6% | 0.02% | +10.0% |
| Q3 2022 | $24,703,000 | +120.7% | 526,252 | +75.4% | 0.02% | +150.0% |
| Q2 2022 | $11,191,000 | +58.9% | 299,950 | +27.3% | 0.01% | +100.0% |
| Q1 2022 | $7,043,000 | -12.3% | 235,545 | +0.5% | 0.00% | -20.0% |
| Q4 2021 | $8,027,000 | +17.1% | 234,439 | +26.8% | 0.01% | +25.0% |
| Q3 2021 | $6,855,000 | -0.9% | 184,925 | +4.4% | 0.00% | 0.0% |
| Q2 2021 | $6,916,000 | +31.5% | 177,105 | +43.3% | 0.00% | 0.0% |
| Q1 2021 | $5,260,000 | – | 123,572 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $21,500,000 | 16.53% |
| Velan Capital Investment Management LP | 293,385 | $10,946,000 | 11.10% |
| Paradigm Biocapital Advisors LP | 667,417 | $24,901,000 | 4.96% |
| RTW INVESTMENTS, LP | 3,996,154 | $149,097,000 | 3.85% |
| Rock Springs Capital Management LP | 2,671,652 | $99,679,000 | 2.90% |
| TANG CAPITAL MANAGEMENT LLC | 385,600 | $14,387,000 | 2.18% |
| Samsara BioCapital, LLC | 160,963 | $6,006,000 | 1.60% |
| Avidity Partners Management LP | 1,350,000 | $50,369,000 | 1.16% |
| Pier Capital, LLC | 123,394 | $4,604,000 | 0.78% |
| Omega Fund Management, LLC | 51,535 | $1,923,000 | 0.61% |